(2014). Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics (Evanston), 134(2), e620. https://doi.org/10.1542/peds.2014-1666
Chicago Style (17th ed.) Citation"Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection." Pediatrics (Evanston) 134, no. 2 (2014): e620. https://doi.org/10.1542/peds.2014-1666.
MLA (9th ed.) Citation"Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection." Pediatrics (Evanston), vol. 134, no. 2, 2014, p. e620, https://doi.org/10.1542/peds.2014-1666.